Fusogenic Lipid Nanovesicles as Multifunctional Immunomodulatory Platforms for Precision Solid Tumor Therapy
Small · 2025
DOI: 10.1002/smll.202503134 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, 2025. Verfasst von Xu Ou und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Beijing Institute of Technology, Beijing, 100081, P. R. China. Hauptthemen laut MEDLINE: Neoplasms, Lipids, Nanoparticles, Precision Medicine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 195 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, Natural Science Foundation of Shandong Province, National Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Although immunotherapy demonstrates considerable prospect in overcoming solid tumors, its clinical efficacy is limited by several factors, such as poor tumor immunogenicity, inadequate immune activation, and immunosuppressive tumor microenvironment (TME). To overcome these challenges, a versatile and universal immune modulation platform should be developed, and lipid nanovesicles with membrane fusion capabilities (LNV‐Fs) have attracted great attention for this purpose. By mimicking natural membrane fusion processes, LNV‐Fs enable the precise presentation of immunogenic components on tumor cell membranes, effectively activating anti‐tumor immune surveillance. Similarly, LNV‐Fs can equip multiple functionalities on autologous and adoptive effector cells for enhanced cell therapies. Additionally, LNV‐Fs function as vaccines that elicit robust autologous anti‐tumor immunity while promoting long‐term immune memory. Furthermore, different LNV‐Fs with powerful ability in reprogramming TME have been reported. Given the recent advancements and the absence of comprehensive reviews on this topic, a comprehensive analysis of LNV‐F systems, including their structural classifications, membrane fusion mechanisms, and recent applications in cancer immunotherapy is provided. Furthermore, the future prospects of LNV‐Fs, with particular emphasis on artificial intelligence‐assisted design are explored. This review is intended to engage researchers from diverse interdisciplinary fields and provide valuable insights for advancing precision immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science, Beijing Institute of Technology, Beijing, 100081, P. R. China.
- Chemical Biology Center Peking University State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Beijing, 100191, P. R. China.
ORCID-Profile: Weidong Nie
Förderung
- Beijing Natural Science Foundation
- Natural Science Foundation of Shandong Province
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Beijing Institute of Technology Research Fund Program for Young Scholars
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Ou, X., Zhou, J., Xie, H. Y., & Nie, W. (2025). Fusogenic Lipid Nanovesicles as Multifunctional Immunomodulatory Platforms for Precision Solid Tumor Therapy. Small. https://doi.org/10.1002/smll.202503134
Vancouver
Ou X, Zhou J, Xie HY, Nie W. Fusogenic Lipid Nanovesicles as Multifunctional Immunomodulatory Platforms for Precision Solid Tumor Therapy. Small. 2025. doi:10.1002/smll.202503134
BibTeX
@article{Ou2025,
author = {Ou, Xu and Zhou, Jiaxin and Xie, Hai-Yan and Nie, Weidong},
title = {Fusogenic Lipid Nanovesicles as Multifunctional Immunomodulatory Platforms for Precision Solid Tumor Therapy},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202503134}
}
EUVIMED